More than ever, life sciences companies are going public to raise capital for future growth. In fact, U.S. equity financing in life sciences skyrocketed to a record $7 billion in 2018—a…
Read the full article at: www.jdsupra.com
from LocalWeeklyPaper.com https://localweeklypaper.com/post/182680585442